Articles by John McCalister
APF530 is a drug that has been developed by A.P. Pharma Inc. (Nasdaq:APPA) using its “Biochronomer™ polymer-based drug delivery technology”.
Duratech™ BioRegeneration Matrix is a medical device that has been devekioed by Osteotech, Inc (Nasdaq:OSTE). Now the company wants to bring this product into the market. However, it needs the approval from the United States …
BEMA Granisetron is a product candidate that has been developed by BioDelivery Services International, Inc. (Nasdaq:BDSI). According to the company, this product can reduce vomiting and nausea.
Exenatide is a drug that has been co-developed by Amylin Pharmaceuticals, Inc, (Nasdaq:AMLN), Alkermes, Inc. (Nasdaq: ALKS) and Eli Lilly and Company (NYSE:LLY). Exenatide is currently available in the market as BYETTA® injections. However, now …
Pirfenidone is a drug that has been developed by Intermune, Inc. (Nasdaq:ITMN). According to the company, this drug can be used to treat patients suffering from idiopathic pulmonary fibriosis (IPF) by keeping the lungs healthy.
Picoplatin is a type of cancer drug developed by Poniard Pharmaceuticals, Inc. (Nasdaq:PARD). On January 7, 2010, the company announced that it wanted to form a strategic partnership so that it could continue develop picoplatin …
Eisai Co., Ltd. is a corporation that is operating in several countries across the world. It has a number of companies in the United States of America, too, such as Morphotek, Inc. (which sells specialized …
NexMed, Inc. (Nasdaq:NEXM) is a specialty contract research organization – also called clinical research organization (CRO). It has decades’ experience of providing “in vitro and in vivo pharmacology services and research models”.
CombinatoRx, Incorporated (NASDAQ:CRXX) and Neuromed Pharmaceuticals Inc., two companies which have merged into one on June 30, 2009, have developed a drug called Exalgo™ (the brand name for hydromorphone HCl).
Tissue Repair Company is a subsidiary of Cardium Therapeutics, Inc. (NYSE Amex:CXM). The former already submitted a 510(K) premarket notification application to the United States of America’s Food & Drug Administration (FDA).
